Nikolai Petrovsky

Affiliation: Vaxine Pty Ltd., Adelaide, SA 5046, Australia
Institution: Vaxine Pty Ltd.
ORCID: 0000-0002-1580-5245
External IDs: ResearcherID: P-1912-2017 | Scopus Author ID: 7004919225 | SciProfiles: 619551
Email: n.petrovsky@vaxine.net
Works: 87, Cited by: 1421, H-index: 25
Leading researcher in vaccine development and immunology.

Education

  • PhD, University of Adelaide (2000-2004)

Research Interests

Keywords:
vaccines adjuvants autoimmunity immunomics bioinformatics
Topics:
Vaccine Development Immunology Bioinformatics

Professional Links

Selected Publications

Advax enhances ant venom therapy
Wanandy T, Honda-Okubo Y, Davies NW, Rose HE, Heddle RJ, et al. Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy. J Pharm Biomed Anal. 2019;172:1. doi:10.1016/j.jpba.2019.04.017
PubMed DOI

Related Products